On this page

Naloxone is a short-acting opioid antagonist medicine that reverses the effects of opioid overdose.

NSW Health delivers a Take Home Naloxone Program to reduce the mortality and morbidity for people across NSW who use opioid drugs or medicines. Through this program, a range of health workers can play a role in ensuring naloxone is available to people in the NSW community who are likely to need it.

Trained, credentialed workers at NSW public health needle and syringe programs and alcohol and other drugs services and at participating non-government organisations and private services can supply take home naloxone at no cost to consumers, carers or family members, and provide a brief intervention about how to use the medicine.

Two formulations of naloxone are provided in the NSW Program – a pre-filled syringe for injection and an intranasal spray.

Community members can visit Your Room for more information about naloxone and visit NUAA for ways to stay safe when using opioid drugs.

COVID-19, rescue breathing and chest compressions

The take home naloxone program includes instructions for clients to perform rescue breathing and chest compressions. Before doing so, refer to the National COVID-19 Clinical Evidence Taskforce guidance on basic life support for adults in the community during the COVID-19 pandemic.

 

Information for public, private and NGO services

for non-government and private services

 

Information for community pharmacies

Australian Government take home naloxone pilot

The Australian Government take home naloxone pilot subsidises the cost of naloxone medicines supplied in participating community pharmacies located in NSW, SA and WA.

The pilot commenced in community pharmacies in December 2019 and will continue until 30 June 2022.

The pilot subsidises the full cost of naloxone, including dispensing fee, to participating community pharmacies that supply the medicine to people at risk of witnessing or experiencing an opioid overdose. This includes people on prescribed opioid medicines. A PBS prescription is not required.

Take home naloxone is an important life-saving medicine and should be part of any COVID-19 safety and emergency preparations for people using opioids.

How community pharmacists can get involved:

  1. Register for the pilot.
  2. Order naloxone through your usual ordering channel and promote its availability among staff and patients.
  3. Supply naloxone to eligible patients with advice on how to use naloxone.
    Refer to the consumer medicine information sheet provided with each product or to the NSW Health Consumer information sheet: Nyxoid® or Consumer information sheet: Prenoxad®.
  4. Collect simple de-identified patient data.
  5. Claim reimbursement through the PPA portal and enter patient data.
  6. Re-order naloxone to ensure adequate replacement stock.

Naloxone continues to be available on the PBS with a prescription or as a Schedule 3 medicine.

Free take home naloxone pilot promotional display resources are available for participating services to order using the take home naloxone pilot resource order form.

Community pharmacists should contact the take home naloxone pilot administrator for information on how to register, report evaluation data and be reimbursed.

Phone: 1800 951 285 (9am to 8pm AEST Monday to Friday)
Email:support@ppaonline.com.au
Online: Pharmacy Programs Administrator

Information for general practitioners

The RACGP webinar A guide to naloxone for general practitioners supports GPs to discuss opioid overdose risks with patients who may use opioids; ensure relevant patients can access naloxone; and instruct patients on when and how naloxone should be administered.

[back to top]

Current as at: Monday 6 September 2021